SEATTLE, July 17, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty1 AI Labs, LLC, an innovative subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), is thrilled to announce a strategic partnership with an intent to ...

Using machine learning and a large volume of data on genes and existing drugs, researchers at Lund University in Sweden have identified a combination ...

Knowledge graphs are a powerful tool for bringing together information from biological databases and linking what is already ...

Using machine learning and a large volume of data on genes and existing drugs, researchers at Lund University in Sweden have ...

In a recently accepted manuscript titled “Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data”, scientists from Insilico ...

STANFORD, Calif., Aug. 22, 2025 (GLOBE NEWSWIRE) -- via IBN – ViRx@Stanford, a leading biosecurity and pandemic preparedness initiative, and Fifty1 AI Labs, a subsidiary of Fifty1 Labs, Inc. (OTC: ...

VANCOUVER, British Columbia, Aug. 26, 2025 (GLOBE NEWSWIRE) -- via IBN -- Fifty 1 AI Labs, a subsidiary of Fifty 1 Labs, Inc. (OTC: FITY), has entered a groundbreaking partnership with LUNR Aerospace ...

When David Fajgenbaum was in medical school, he was diagnosed with an incurable illness called Castleman disease. He was 25 years old when doctors told him “there’s nothing we can do,” and a priest ...

Algorithms used for consumer predictions are being retooled to help identify which medicines are optimal and may carry hidden risks for patients. Researchers from Monash University used a different ...

BostonGene has won four awards in the Research & Development, Product Launches, and Innovation categories in the 2025 Pharmaceutical Technology Excellence Awards.

This collaboration integrates BioSpark's proprietary AI and LLM platform with Fifty1 AI Labs' advanced predictive modeling to explore and organize extensive case-based medical literature. BioSpark's ...

"By combining our AI-driven drug repurposing capabilities with LUNR's plans for orbital infrastructure, we will not only be advancing space medicine but also unlock dual-use applications that could ...